CAS Medical Systems Inc. (CASM) posted a fourth-quarter net loss applicable to common stockholders of $2.44 million or $0.18 per share, compared to a loss of $1.95 million or $0.15 per share for the fourth quarter of 2011.
FORE-SIGHT oximetry sales were $2.2 million, an increase of $0.5 million, or 31%, over the fourth quarter of 2011. FORE-SIGHT disposable sensor sales increased $0.5 million, or 36%, to $1.8 million over the prior year period. All other sales were 3.8 million, an increase of $0.1 million, or 4%, over the fourth quarter of 2011
Net sales for the fourth quarter were $6.0 million, compared with $5.3 million last year.
For comments and feedback: editorial@rttnews.com